In the second of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, John Donnelly speaks with Dr. Peter Small, who runs the tuberculosis program at the Gates Foundation, regarding his thoughts on recent developments in the field of TB control and treatment, including the promise of the Gene Xpert rapid TB diagnostic tool. Dr. Small is a member of the Stop TB Partnership’s Coordinating Board, has done extensive research in the genetic variability of tuberculosis, and is a global expert in TB epidemiology, biology and control.
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
CDC announces publication of TB treatment trial results showing four month regimen as effective as six month
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]